ZELTIQ to Present at Canaccord Genuity 33rd Annual Growth Conference
August 14 2013 - 1:29PM
ZELTIQ®, (Nasdaq:ZLTQ) a medical technology company focused on
developing and commercializing products utilizing its proprietary
controlled-cooling technology platform, today announced that Mark
Foley, President and Chief Executive Officer and Patrick F.
Williams, Senior Vice President and Chief Financial Officer, are
scheduled to present at the Canaccord Genuity 33rd Annual Growth
Conference at the InterContinental Boston Hotel in Boston,
Massachusetts.
Event: Canaccord Genuity
33rd Annual Growth Conference |
Date: August 15, 2013 |
Time: 3:30 p.m. ET |
An audio web cast of the Company's presentation will be
available by visiting the investor relations section of ZELTIQ's
web site at www.coolsculpting.com. A replay of the presentation
will be available for 90 days.
About ZELTIQ®
ZELTIQ is a medical technology company focused on developing and
commercializing products utilizing its proprietary
controlled-cooling technology platform. ZELTIQ's first commercial
product, the CoolSculpting System, is designed to selectively
reduce stubborn fat that may not respond to diet or exercise.
CoolSculpting is based on the scientific principle that fat cells
are more sensitive to cold than the overlying skin and surrounding
tissues. It utilizes patented technology of precisely controlled
cooling to reduce the temperature of fat cells in the treated area,
which is intended to cause fat cell elimination through a natural
biological process known as apoptosis. ZELTIQ developed
CoolSculpting to safely, noticeably, and measurably reduce the fat
layer.
CONTACT: Investor Relations:
Patrick F. Williams
ZELTIQ, Senior Vice President and CFO
925-474-2500
Nick Laudico / Rada Milenovici
The Ruth Group
646-536-7030 / 646-536-7011
nlaudico@theruthgroup.com
Zeltiq Aesthetics, Inc. (NASDAQ:ZLTQ)
Historical Stock Chart
From Jun 2024 to Jul 2024
Zeltiq Aesthetics, Inc. (NASDAQ:ZLTQ)
Historical Stock Chart
From Jul 2023 to Jul 2024